Cost Analysis of Aflibercept 8 mg Versus Aflibercept 2 mg for the Treatment of Diabetic Macular Edema in the PHOTON Trial.

Chaaya C, Zhang S, Hoffman SE, Bhatnagar A, Hoyek S, Meshkin RS, Yannuzzi NA, Al-Khersan H, Patel NA

DOI: 10.1177/24741264261469696
Published: 2026 Jul 21
Container: Journal of vitreoretinal diseases
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/24741264261469696,
  title = {Cost Analysis of Aflibercept 8 mg Versus Aflibercept 2 mg for the Treatment of Diabetic Macular Edema in the PHOTON Trial.},
  author = {Chaaya C and Zhang S and Hoffman SE and Bhatnagar A and Hoyek S and Meshkin RS and Yannuzzi NA and Al-Khersan H and Patel NA},
  year = {2026},
  journal = {Journal of vitreoretinal diseases},
  doi = {10.1177/24741264261469696},
  url = {https://doi.org/10.1177/24741264261469696}
}

RIS

TY  - JOUR
TI  - Cost Analysis of Aflibercept 8 mg Versus Aflibercept 2 mg for the Treatment of Diabetic Macular Edema in the PHOTON Trial.
AU  - Chaaya C
AU  - Zhang S
AU  - Hoffman SE
AU  - Bhatnagar A
AU  - Hoyek S
AU  - Meshkin RS
AU  - Yannuzzi NA
AU  - Al-Khersan H
AU  - Patel NA
PY  - 2026
JO  - Journal of vitreoretinal diseases
DO  - 10.1177/24741264261469696
UR  - https://doi.org/10.1177/24741264261469696
ER  -

APA

C, C., S, Z., SE, H., A, B., S, H., RS, M., NA, Y., H, A., & NA, P. (2026). Cost Analysis of Aflibercept 8 mg Versus Aflibercept 2 mg for the Treatment of Diabetic Macular Edema in the PHOTON Trial.. Journal of vitreoretinal diseases. https://doi.org/10.1177/24741264261469696

Source records

pubmed · retrieved 2026-09-26T05:44:22.200Z